Trial Profile
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 01 Mar 2023
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Lonafarnib (Primary)
- Indications Progeria
- Focus Adverse reactions; Therapeutic Use
- 23 Feb 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.
- 11 Jun 2021 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.
- 11 Jun 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2022.